SANA Stock Up 53% after 7-Day Win Streak

SANA: Sana Biotechnology logo
SANA
Sana Biotechnology

Sana Biotechnology (SANA) stock hit day 7 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 53% return. The company has gained about $511 Mil in value over the last 7 days, with its current market capitalization at about $962 Mil. The stock remains 156.4% above its value at the end of 2024. This compares with year-to-date returns of 6.4% for the S&P 500.

Comparing SANA Stock Returns With The S&P 500

The following table summarizes the return for SANA stock vs. the S&P 500 index over different periods, including the current streak:

Return Period SANA S&P 500
1D 3.0% -0.3%
7D (Current Streak) 53.1% 0.9%
1M (21D) 47.7% 4.2%
3M (63D) 211.9% 25.6%
YTD 2025 156.4% 6.4%
2024 -60.0% 23.3%
2023 3.3% 24.2%
2022 -74.5% -19.4%

Gains and Losses Streaks: S&P 500 Constituents

There are currently 42 S&P constituents with 3 days or more of consecutive gains and 50 constituents with 3 days or more of consecutive losses.

Consecutive Days # of Gainers # of Losers
3D 23 24
4D 15 15
5D 0 4
6D 2 4
7D or more 2 3
Total >=3 D 42 50

 

Relevant Articles
  1. Figure’s Take Rate Is Shrinking By Design
  2. Make Your TDG Shares Pay You 9.8% A Year While You Hold Them
  3. The Options Market Puts PayPal Stock Between The High Forties And The High Seventies
  4. What Could Power The Next Rally In McDonald’s Stock
  5. What You Are Really Paying For In Arista Networks Stock
  6. SanDisk Looks Cheap On Consensus, But The Payoff Sits In Its Contracts

Key Financials for Sana Biotechnology (SANA)

Last 2 Fiscal Years:

Metric FY2023 FY2024
Revenues
Operating Income $-293.1 Mil $-272.7 Mil
Net Income $-283.3 Mil $-266.8 Mil

Last 2 Fiscal Quarters:

Metric 2024 FQ4 2025 FQ1
Revenues
Operating Income $-50.9 Mil $-50.6 Mil
Net Income $-49.1 Mil $-49.4 Mil

While SANA stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.